Abstract:Prednisone (PRED) is a synthetic glucocorticoid (GC) widely used in immunemediated diseases for its immunosuppressive and anti-inflammatory properties. The effects of GC are achieved by genomic and nongenomic mechanisms. However, the nongenomic effects are largely unknown. Thus, we aimed to investigate how long-term prednisone therapy changes the composition of the gut microbiota and fecal metabolites in rats. Male Sprague-Dawley rats were randomly assigned to a control (CON) group and a PRED group, which received prednisone treatment daily for 6 weeks by gavage. The V3 to V4 regions of bacterial 16S rRNA genes were amplified and sequenced after the total bacterial DNA was extracted from fecal samples. The alpha and beta diversities were calculated. The compositional alteration of the gut microbiota at different taxonomic levels was analyzed using the Metastats method. Meanwhile, the fecal metabolites were quantitated in an ultra-performance liquid chromatography system. Similar microbial richness and diversity between the CON and PRED groups were indicated by the alpha diversity results. The gut microbial communities differed significantly between two groups. The relative abundances of the genera Eisenbergiella, Alistipes, and Clostridium XIVb decreased, whereas that of Anaerobacterium increased significantly in rats after the 6-week prednisone treatment. In total, 11 downregulated and 10 upregulated fecal metabolites were identified. Differential fecal metabolites were enriched in the pathways, including phenylalanine metabolism, butanoate metabolism, and propanoate metabolism. The lowered production of short-chain fatty acids was associated with the decreased relative abundance of the genera Alistipes and Clostridium XIVb and increased abundance of the genus Anaerobacterium. The composition of the gut microbiota and fecal metabolites was changed after long-term prednisone treatment. This may help us to understand the pharmacology of prednisone. IMPORTANCE Prednisone is widely used in chronic glomerular diseases, immunological disorders, and rheumatic diseases for its anti-inflammatory and immunosuppressive properties. It is a synthetic glucocorticoid (GC) that shows therapeutic effects after conversion to prednisolone by the liver. Prolonged GC therapy causes anti-inflammatory effects; it also results in a variety of adverse events, including obesity, hypertension, psychiatric symptoms, and dyslipidemia. The therapeutic effects and adverse events of GCs may be associated with changes in the gut microbiota, as the host might be affected by the metabolites generated by the altered gut microbes. Thus, we investigated how long-term prednisone therapy changed the composition of the gut microbiota and fecal metabolites in rats. This study may shed new light on the pharmacology of prednisone.

Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease

Limited Preventive Effect of Prednisone on Neuropsychiatric Symptoms in Murine Systemic Lupus Erythematosus

Analysis of Brain Metabolites by Gas Chromatography–mass Spectrometry Reveals the Risk–benefit Concerns of Prednisone in MRL/lpr Lupus Mice

Prednisone acetate modulates Th1/Th2 and Th17/Treg cell homeostasis in experimental autoimmune uveitis via orchestrating the Notch signaling pathway

Revisit the Inhibitory Effects of Glucocorticoids on Immunocytes

Timing of glucocorticoid administration determines severity of lipid metabolism and behavioral effects in rats.

Cell-type specific impact of glucocorticoid receptor activation on the developing brain

Glucocorticoids improve the balance of M1/M2 macrophage polarization in experimental autoimmune uveitis through the P38MAPK-MEF2C axis

Long-term Prednisone Treatment Causes Fungal Microbiota Dysbiosis and Alters the Ecological Interaction Between Gut Mycobiome and Bacteriome in Rats

New Aspects of the Mechanisms of Glucocorticoid Actions on the Brain

Control of immunity by glucocorticoids in health and disease

Glucocorticoids Impair Microglia Ability to Induce T Cell Proliferation and Th1 Polarization.

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment

Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapse

Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution

Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway.

Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids

Global analysis of the abundance of AU-rich mRNAs in response to glucocorticoid treatment

Chronic exposure to glucocorticoids amplifies inhibitory neuron cell fate during human neurodevelopment in organoids

Combined Treatment with Minocycline and Prednisone Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice.